Skip to content
Open access

DNA methylation and proteomic profiling of postmortem brain tissue reveals epigenetic dysregulation and inflammatory signaling in fragile X-associated tremor/ataxia syndrome

Oct 2026 · Frontiers in Molecular Neuroscience · Vol 19 · 0 citations · 53 references
Medicine

TL;DR

Findings identify previously unrecognized DNA methylation alterations in FXTAS prefrontal cortex involving genes related to oxidative stress, myelination, zinc homeostasis, and innate immune/NF-κB signaling.

Abstract

Background Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder caused by a CGG repeat expansion in the premutation range of FMR1. The epigenetic landscape of the FXTAS brain remains largely uncharacterized. We performed genome-wide DNA methylation profiling of postmortem prefrontal cortex and targeted proteomic profiling to investigate molecular alterations associated with FXTAS and evaluate convergence on inflammatory signaling. Methods DNA methylation was profiled in postmortem prefrontal cortex from 27 male FXTAS cases and 29 male controls using Illumina MethylationEPIC arrays. Surrogate variable analysis was used to account for latent sources of variation. Differentially methylated positions (DMPs) were defined as well as differentially methylated regions (DMRs). Exploratory functional analyses and comparison with published FXTAS transcriptomic and neurodegenerative-disease methylation datasets. Targeted proteomic profiling using the Olink Inflammation panel was performed in 9 male FXTAS cases and 12 male controls. Results We identified 98 DMPs which mapped to 70 genes. Notable DMP-associated genes included CYP2E1, related to oxidative stress; TRAF3, BATF, RCOR1, and MSI2, with roles in immune and NF-κB-related signaling; and genes associated with myelination (LINGO1), synaptic function (SYT3), and zinc homeostasis (SLC39A4). TRAF3, a negative regulator of NF-κB and type I interferon signaling, contained one of the most significant DMPs. Exploratory Reactome analysis highlighted biological themes related to inflammatory resolution, axonal growth inhibition, zinc homeostasis, and CYP2E1 metabolism, although no pathway remained significant after multiple-testing correction. Transcription-factor motif enrichment and protein–protein interaction analyses identified no significant higher-order regulatory or interaction modules. Seven DMP-associated genes overlapped with differentially expressed genes from an independent FXTAS mouse transcriptomic study, whereas no gene-level overlap was detected with the Alzheimer’s, Parkinson’s, or Huntington’s disease methylation signatures examined. Olink profiling identified 60 significantly altered inflammation-related proteins, 59 of which showed lower abundance in FXTAS, including TLR3, IRAK1, IRAK4, IKBKG/NEMO, and C1QA. Conclusion These findings identify previously unrecognized DNA methylation alterations in FXTAS prefrontal cortex involving genes related to oxidative stress, myelination, zinc homeostasis, and innate immune/NF-κB signaling. Convergence between methylation changes in immune-regulatory genes, including TRAF3, and a predominantly reduced inflammatory protein signature provides complementary evidence for altered inflammatory signaling in FXTAS.

Read PDF

Similar papers

Open access Oct 2026

Brain DNA methylation, APOE genotype and Alzheimer’s disease neuropathology in a large postmortem cohort

DNA methylation (DNAm) plays a critical role in Alzheimer’s disease (AD). Previous epigenome-wide association studies using 450K arrays captured limited CpG coverage and often focused on a single neuropathological measure. Here we profiled DNAm in 1,250 postmortem prefrontal cortex samples from the Rush Alzheimer’s Dis...

G. Miao, Cheng Gao, Lei Yu et al. · 0 citations
Review Nov 2026

From epigenetic marks to biomarker qualification in fetal alcohol spectrum disorder: a critical review of DNA methylation, chromatin and regulatory RNA.

INTRODUCTION Fetal alcohol spectrum disorder (FASD) is a preventable cause of neurodevelopmental disability, yet diagnosis remains multidisciplinary and affected people may be identified late. Epigenetic research has expanded since the 2017-2018 primer series. AREAS COVERED This critical narrative review evaluates DN...

C. Mandal, K. Jung, Y. Chai · 0 citations
Open access Sep 2026

Cell-type-resolved DNA methylation profiling in the cortex reveals female-specific X chromosome differences in autism

Cell-type-specific autism-associated differentially methylated positions (DMPs) are identified and a striking female-specific signature concentrated on the X chromosome in microglia is revealed, supporting the importance of microglia in autism and suggesting that altered X chromosome dosage regulation may contribute to...

Alice Franklin, Jonathan P. Davies, B. Chioza et al. · 0 citations
Open access Mar 2025

Interrogating DNA methylation associated with Lewy body pathology in a cross brain-region and multi-cohort study

Lewy body (LB) diseases are an umbrella term encompassing a range of neurodegenerative conditions all characterized by the hallmark of intra-neuronal -synuclein associated with the development of motor and cognitive dysfunction. In this study, we have conducted a large meta-analysis of DNA methylation across multiple c...

Joshua Harvey, J. Imm, Morteza Kouhsar et al. · 6 citations
Meta-analysis Open access Sep 2026

Interrogating DNA methylation associated with Lewy body pathology in a cross brain-region and multi-cohort study

Here, we conduct a large meta-analysis of DNA methylation across multiple cortical brain regions, in relation to increasing burden of Lewy body pathology. Utilizing a dataset of 1205 samples (832 unique donors), we identify 24 false discovery rate significant differentially methylated loci associated with Lewy body pat...

Joshua Harvey, J. Imm, Morteza Kouhsar et al. · 0 citations
Open access Sep 2026

Genetically Predicted Blood DNA Methylation Reveals Putative Regulatory Signals Associated with ALS Risk

PrediXcan-based MWAS of genetically predicted blood DNA methylation provides a complementary strategy for refining genetic association signals into biologically testable candidates and identifying regulatory mechanisms for further functional investigation, and adds a regulatory dimension to ALS genetic studies.

Tian-Ying Zhao, M. Hoffman, Gang Wu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.